Dipyridamole-thallium imaging: minimum dose requirements.


A total of 372 consecutive dipyridamole-thallium studies were reviewed to determine if a relationship existed between the dose of dipyridamole administered and the likelihood that thallium images would show reversible defects. Men who received a dose of less than 31 mg were less likely to have thallium redistribution (P = 0.0001). Until the ideal study… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.